Pages without language links

Jump to: navigation, search

The following pages do not link to other language versions.

Showing below up to 100 results in range #1 to #100.

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

  1. 10 common errors in surveillance evaluations
  2. About
  3. Acquired resistance
  4. Additional resources for presenting findings
  5. Advantages and Disadvantages of Questionnaires
  6. Advantages and disadvantages of cohort and case control studies
  7. Advantages and disadvantages of matching
  8. Aesthetic preferences
  9. Aide memoire for oral presentations and visual aids
  10. Analysis, Interpretation, and Dissemination
  11. Analysis by person characteristics
  12. Analytical Study Designs
  13. Antibodies
  14. Antigen presenting cells (APC)
  15. Antigens (Ag)
  16. Antimicrobial resistance
  17. Antimicrobial stewardship
  18. Applying Epidemiology for the International Health Regulations.
  19. Apps for epidemiologists
  20. Ascertainment Bias
  21. Attack rate
  22. Bar graphs
  23. Bias in Questionnaires
  24. Bioinformatics
  25. Bloodstream Infection
  26. Bone and Joint Infection
  27. Brief history of International Communicable Disease Law
  28. Burden of HAIs
  29. CAUTI
  30. CLABSI
  31. Capture-recapture
  32. Cardiovascular System Infection
  33. Case-cohort study
  34. Case cross over studies
  35. Case to case study design
  36. Catheter-Related Infection
  37. Causal mechanisms
  38. Central Nervous System Infection
  39. Checklist for posters
  40. Checklist for study protocols
  41. Choosing a method of data display
  42. Choosing an appropriate type of map
  43. Clinical role of the microbiology laboratory
  44. Cognitive bias
  45. Cohorting patients and/or staff
  46. Combining Studies: Meta-Analysis
  47. Common errors in surveillance data analysis
  48. Concepts in sampling
  49. Confidence Intervals
  50. Confounding in studies
  51. Contact precautions
  52. Contact tracing
  53. Continuing Source
  54. Control Selection
  55. Cooperative learning as active learning in adult
  56. Cost-effectiveness
  57. Cost-minimisation
  58. Cost-utility
  59. Crisis communication
  60. Criteria for Surveillance
  61. Criteria for confounding
  62. Cross-sectional Studies
  63. Data collection instrument
  64. Defining a Case
  65. Definition of an Outbreak Investigation Report
  66. Density case control studies
  67. Descriptive Studies
  68. Detection Bias
  69. Developing a control definition
  70. Developing infection control interventions: isolation
  71. Diagnostic Applications of the Epidemic Curve
  72. Diagnostic bias
  73. Diagnostic tests versus screening test
  74. Disasters and Emergencies
  75. Disentangling Complex Data
  76. Distinguishing Different Sources or Modes of Transmission during an outbreak
  77. Dose Effect
  78. ECDC PPS - antimicrobial use definition
  79. ECDC PPS - inclusion/exclusion criteria
  80. ECDC PPS in European acute care hospitals, definition of HAI
  81. ECDC PPS in European acute care hospitals protocol
  82. ECDC Programme on antimicrobial resistance and healthcare-associated infections
  83. ECDC point prevalence survey of healthcare-associated infections and antimicrobial use in long term care facilities
  84. ECDC surveillance of Surgical Site Infections
  85. EU Food Safety Legislation
  86. EU Legislation for Communicable Diseases Surveillance
  87. Education and training of staff
  88. Effect Modification
  89. Electronic Data Transfer
  90. Environment as a source of healthcare-associated infections
  91. Epidemiological/public health role of the clinical microbiology laboratory
  92. Erythema infectiosa
  93. Estimating Odds Ratios in the presence of interaction
  94. European Antimicrobial Resistance Surveillance Network (EARS-Net)
  95. European Surveillance of Antimicrobial Consumption Network (ESAC-Net)
  96. Evaluation of Screening
  97. Evaluation of the microbicidal activities of hand-rub and hand-wash agents
  98. Event-based Surveillance
  99. Experimental Studies
  100. Expert Advice

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)